Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Serina Therapeutics (SER) Intangibles (2017 - 2024)

Serina Therapeutics (SER) has disclosed Intangibles for 8 consecutive years, with $509000.0 as the latest value for Q3 2024.

  • Quarterly Intangibles fell 20.47% to $509000.0 in Q3 2024 from the year-ago period, while the trailing twelve-month figure was $509000.0 through Sep 2024, down 20.47% year-over-year, with the annual reading at $738000.0 for FY2022, 15.17% down from the prior year.
  • Intangibles hit $509000.0 in Q3 2024 for Serina Therapeutics, down from $541000.0 in the prior quarter.
  • In the past five years, Intangibles ranged from a high of $2.0 million in Q1 2020 to a low of $509000.0 in Q3 2024.
  • Historically, Intangibles has averaged $1.0 million across 5 years, with a median of $853500.0 in 2021.
  • Biggest five-year swings in Intangibles: surged 56.75% in 2023 and later tumbled 56.1% in 2024.
  • Year by year, Intangibles stood at $1.6 million in 2020, then plummeted by 45.35% to $870000.0 in 2021, then dropped by 15.17% to $738000.0 in 2022, then decreased by 13.28% to $640000.0 in 2023, then decreased by 20.47% to $509000.0 in 2024.
  • Business Quant data shows Intangibles for SER at $509000.0 in Q3 2024, $541000.0 in Q2 2024, and $576000.0 in Q1 2024.